Related Experiment Videos
The AP1 transcription factor Fra2 is required for efficient cartilage development
Florian Karreth1, Astrid Hoebertz, Harald Scheuch
1Research Institute of Molecular Pathology (I.M.P. Vienna, Austria.
Development (Cambridge, England)
|October 29, 2004
Summary
The transcription factor Fra2 (Fosl2) is crucial for skeletal development. Its absence impairs chondrocyte differentiation and matrix deposition, leading to growth defects and spinal abnormalities in mice.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- The Fos-related AP1 transcription factor Fra2, encoded by Fosl2, is present in epithelial and cartilaginous tissues.
- Its specific role in cartilage development and skeletogenesis remains largely uncharacterized.
Purpose of the Study:
- To investigate the function of Fra2 in cartilage development and its impact on chondrocyte differentiation and skeletogenesis.
Main Methods:
- Analysis of Fra2-deficient (Fosl2-/-) embryos and newborn mice.
- In vitro studies using primary chondrocytes from Fosl2-/- mice.
- Generation and analysis of conditional knockout mice (coll2a1-Cre, Fosl2f/f) to study postnatal cartilage development.
Main Results:
- Absence of Fra2 leads to reduced hypertrophic chondrocyte zones and impaired matrix deposition in growth plates.
- Fra2 deficiency causes delayed hypertrophic differentiation and ossification in vertebral development.
- Primary Fosl2-/- chondrocytes show decreased hypertrophic differentiation and prolonged proliferation.
- Conditional knockout mice exhibit growth retardation, smaller growth plates, and kyphosis.
Conclusions:
- Fra2 is a novel transcription factor essential for normal skeletogenesis.
- Fra2 plays a critical role in regulating chondrocyte differentiation during skeletal development.
- Dysregulation of Fra2 impacts both embryonic and postnatal cartilage development, leading to significant skeletal abnormalities.